Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Terumo Corp ADR (TRUMY)

Terumo Corp ADR (TRUMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Why Shares of Orchestra BioMed Jumped Tuesday Motley Fool - Tue Sep 19, 2023

The company got approval from the FDA to go ahead with a pivotal study for a hypertension therapy.

MDT : 81.76 (+0.09%)
TRUMY : 17.5200 (+0.75%)
OBIO : 5.24 (+2.75%)
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029 FinancialNewsMedia - Thu Jan 12, 2023

EQNX::TICKER_START (NASDAQ:STSS),(NYSE:BDX),(NYSE:CAH),(NYSE:NVO),(OTCPK:TRUMY),(NASDAQ:STSSW) EQNX::TICKER_END

STSSW : 0.0850 (+54.55%)
STSS : 0.2464 (+7.04%)
BDX : 236.58 (+0.81%)
CAH : 98.59 (-0.32%)
NVO : 124.59 (+1.25%)
TRUMY : 17.5200 (+0.75%)
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029 PR Newswire - Thu Jan 12, 2023

/PRNewswire/ -- The drug delivery system is a device that enables the introduction of a drug in the body and improves its efficacy and safety by controlling...

TRUMY : 17.5200 (+0.75%)
STSS : 0.2464 (+7.04%)
BDX : 236.58 (+0.81%)
CAH : 98.59 (-0.32%)
NVO : 124.59 (+1.25%)

Barchart Exclusives

After Its Historic Dividend Cut, Is 3M Stock Still Worth Buying? Barchart - Mon May 6, 6:30PM CDT
3M stock is a Dividend King no more, as the company slashed its payout following the Solventum spinoff. Is the stock still a buy for investors seeking passive income? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot